Vaccine Clinical Trials – A Statistical Primer

Author： Mehrotra D. V.  

Publisher： Taylor & Francis Ltd

ISSN： 1054-3406

Source： Journal of Biopharmaceutical Statistics, Vol.16, Iss.4, 2006-07, pp. : 403-414

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Trials Simulation: A Statistical Approach

By Westfall Peter  

Journal of Biopharmaceutical Statistics, Vol. 18, Iss. 4, 2008-07 ,pp. : 611-630

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Designs for Early Phases of Cancer Clinical Trials

By Guan Shanhong  

Journal of Biopharmaceutical Statistics, Vol. 22, Iss. 6, 2012-11 ,pp. : 1109-1126

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Considerations for NonInferiority/Equivalence Trials in Vaccine Development

By Wang W. W. B.   Mehrotra D. V.   Chan I. S. F.   Heyse J. F.  

Journal of Biopharmaceutical Statistics, Vol. 16, Iss. 4, 2006-07 ,pp. : 429-441

Taylor & Francis Ltd

Access to resources Recommend Favorite

Handling Missing Data in Vaccine Clinical Trials for Immunogenicity and Safety Evaluation

By Li Xiaoming   Wang William   Liu Guanghan   Chan Ivan  

Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 2, 2011-03 ,pp. : 294-310

Taylor & Francis Ltd

Access to resources Recommend Favorite

Statistical Methods to Analyze Adverse Events Data of Randomized Clinical Trials

By Siddiqui Ohidul  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 5, 2009-09 ,pp. : 889-899

Taylor & Francis Ltd

Access to resources Recommend Favorite